ASX:MVF Monash IVF Group (MVF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Monash IVF Group Stock (ASX:MVF) 30 days 90 days 365 days Advanced Chart Get Monash IVF Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume9.00 million shsAverage VolumeN/AMarket CapitalizationA$455.87 millionP/E RatioN/ADividend Yield4.27%Price TargetN/AConsensus RatingN/A Company Overview Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia. Read More Receive MVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Monash IVF Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MVF Stock News HeadlinesDoes Macquarie rate Monash IVF shares a buy, hold, or sell post-results?August 26, 2025 | msn.comMonash IVF share price plunges 18% on lower FY26 profit guidance and no dividendAugust 23, 2025 | msn.comThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.September 2 at 2:00 AM | Paradigm Press (Ad)Monash IVF Group Ltd Releases FY25 Results PresentationAugust 22, 2025 | msn.comFertility giant to keep review secret after two IVF bunglesAugust 20, 2025 | msn.comMonash IVF Group Completes Review of Clinic IncidentsAugust 20, 2025 | msn.comMonash IVF’s shares have plunged 25pc. This fundie says buy it nowAugust 12, 2025 | afr.comThis Monash IVF Group Insider Increased Their Holding In The Last YearAugust 5, 2025 | finance.yahoo.comSee More Headlines MVF Stock Analysis - Frequently Asked Questions How were Monash IVF Group's earnings last quarter? Monash IVF Group Limited (ASX:MVF) announced its quarterly earnings data on Monday, August, 27th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. Monash IVF Group had a negative trailing twelve-month return on equity of 2.52% and a negative net margin of 2.56%. What other stocks do shareholders of Monash IVF Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX). Company Calendar Last Earnings8/27/2018Today9/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryFinancial Services Current SymbolASX:MVF CIKN/A Webwww.monashivfgroup.com.au Phone+61-3-94208235FaxN/AEmployees997Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth8.25Net Income-A$6.53 million Net Margins-2.56% Pretax MarginN/A Return on Equity-2.52% Return on Assets-0.62% Debt Debt-to-Equity Ratio55.96 Current Ratio0.47 Quick Ratio0.43 Sales & Book Value Annual SalesA$255.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow27.14 Book ValueA$0.64 per share Price / BookN/AMiscellaneous Outstanding Shares389,640,000Free FloatN/AMarket CapA$455.87 million OptionableNot Optionable Beta1.40 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (ASX:MVF) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monash IVF Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Monash IVF Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
